HomeHong KongPrenetics Raises US$10M in Series A Funding

Prenetics Raises US$10M in Series A Funding

-

preneticsPrenetics, a Hong Kong-based DNA biotechnology company specializing in pharmacogenomics, raised US$10M in Series A funding.

The round was led by Ping An Ventures, the venture capital arm of Ping An Insurance Group, with participation from Venturra Capital, Capital Union Investments and existing investors 500 Startups, and Coent Venture Partners.

Led by Danny Yeung, CEO, Prenetics is aĀ precision medicine life sciences company focused on personalized, predictive and preventive treatments.Ā ItsĀ proprietary iGenes test allows physicians to help patients identify the right drug, right dosage andĀ to list out potential adverse drug effects (ADEs), based on one’s genetic profile.

Originated as part of the Biomedical Science Research Centre in City University Hong Kong, PreneticsĀ officially spun off as an independent company in 2009.

FinSMEs

16/03/2016

 

THE DAILY NEWSLETTER - SIGNUP